Central Nervous System (CNS) involvement
Showing 1 - 25 of >10,000
CNS Involvement in Primary Mediastinal Large B-Cell Lymphoma
Active, not recruiting
- Primary Mediastinal Large B-cell Lymphoma (PMBCL)
- DISEASE
- (no location specified)
May 4, 2023
Primary Mediastinal Large B-cell Lymphoma With CNS Involvement
Recruiting
- Primary Mediastinal Large B-cell Lymphoma (PMBCL)
-
Milan, ItalyOspedale San Raffaele
Aug 29, 2023
Non-hodgkin Lymphoma, B Cell Trial in Switzerland (ctDNA detection)
Not yet recruiting
- Non-hodgkin Lymphoma, B Cell
- ctDNA detection
-
Aarau, Switzerland
- +12 more
Oct 18, 2023
CNS Lymphoma Trial in Shanghai (Orelabrutinib, Rituximab, Chemotherapy)
Not yet recruiting
- CNS Lymphoma
- Orelabrutinib
- +2 more
-
Shanghai, Shanghai, ChinaRuijin Hospital, Shanghai Jiao Tong University School of Medicin
Jun 22, 2023
CNS Lymphoma, Secondary CNS Lymphoma Trial run by the National Cancer Institute (NCI) (TEDD-R, TEDDI-R, Ibrutinib)
Recruiting
- Central Nervous System Lymphoma
- Secondary Central Nervous System Lymphoma
- TEDD-R
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Central Nervous System Involvement in Acute Myeloid Leukemia
Recruiting
- Acute Myeloid Leukemia
- Observation of CNS involvement
-
Alessandria, Italy
- +13 more
Dec 31, 2021
Primary Diffuse Large B-cell Lymphoma of the CNS (CNS), Aggressive B-cell Lymphoma With Secondary Involvement of the CNS Trial
Suspended
- Primary Diffuse Large B-cell Lymphoma of the Central Nervous System (CNS)
- Aggressive B-cell Lymphoma With Secondary Involvement of the CNS
- Obinutuzumab
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 6, 2022
Multiple Myeloma Trial in Beijing, Qingdao (SPD:Selinexor Oral Tablet, Pomalidomide, Dexamethasone)
Recruiting
- Multiple Myeloma
- SPD:Selinexor Oral Tablet, Pomalidomide, Dexamethasone
-
Beijing, Beijing, China
- +1 more
Jul 26, 2022
Diffuse Large B Cell Lymphoma, CNS Metastasis Trial in Herlev
Recruiting
- Diffuse Large B Cell Lymphoma
- Central Nervous System Metastasis
-
Herlev, Capital Region, DenmarkHerlev Hopital
Mar 21, 2022
Identify Pediatric Hunter Syndrome Who Demonstrate Evidence of
Completed
- Hunter Syndrome
- Neurobehavioral testing
- Visual and auditory assessments
-
Chapel Hill, North Carolina
- +1 more
May 18, 2021
CNS Lymphoma, Non-Hodgkin Lymphoma Trial in Berlin
Recruiting
- Central Nervous System Lymphoma
- Non-Hodgkin Lymphoma
-
Berlin, GermanyCharité - Universitätsmedizin, Med. Klinik m. S. Hämatologie, On
Nov 8, 2021
HLH Trial in Beijing (Thiotepa)
Recruiting
- HLH
-
Beijing, Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
May 10, 2023
CNS Changes Following Amputation
Recruiting
- Amputation, Congenital
- Upper Limb; Amelia
- MRI
-
Zurich, SwitzerlandBalgrist Campus
Sep 12, 2023
Brain Slice Explants to Predict Drug Response in Brain Tumors
Not yet recruiting
- Central Nervous System Tumor
- Biospecimen collection
-
Chapel Hill, North CarolinaUNC Lineberger Comprehensive Cancer Center
Jul 28, 2023
Reading Problems Associated With Central Nervous System
Completed
- Injury Brain
- +4 more
- eye tracking
-
Valladolid, SpainIOBA - Universidad de Valladolid
Feb 1, 2023
Germ Cell Tumors of the Central Nervous System
Recruiting
- Germ Cell Tumor of CNS
-
Beijing, ChinaSanbo Brain Hospital Capital Medical University
Apr 19, 2023
Primary CNS Lymphoma, Secondary CNS Lymphoma, Relapsed Cancer Trial in Miami (drug, procedure, radiation)
Not yet recruiting
- Primary Central Nervous System Lymphoma
- +3 more
- Pemetrexed
- +3 more
-
Miami, FloridaMiami Cancer Institute at Baptist Health, Inc.
Dec 23, 2022
Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, Recurrent CNS Tumor, Adult Trial in Seattle (SC-CAR4BRAIN)
Not yet recruiting
- Diffuse Intrinsic Pontine Glioma
- +4 more
- SC-CAR4BRAIN
-
Seattle, WashingtonSeattle Children's Hospital
Mar 3, 2023
Longitudinal Study for Central Nervous System Vasculitis
Not yet recruiting
- Central Nervous System Vasculitis
- +3 more
-
Cleveland, Ohio
- +1 more
Feb 8, 2023
CNS Lymphoma, Primary CNS Lymphoma, Secondary CNS Lymphoma Trial in San Francisco (Tafasitamab, Lenalidomide)
Recruiting
- CNS Lymphoma
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Aug 10, 2022
Diffuse Large B Cell Lymphoma, Relapse/Recurrence, Extranodal Extension Trial in Beijing (Low-Dose Decitabine plus anti-PD-1)
Recruiting
- Diffuse Large B Cell Lymphoma
- +3 more
- Low-Dose Decitabine plus anti-PD-1
-
Beijing, Beijing, ChinaChinaPLAGH
Apr 18, 2023